Grasim Industries Limited (LUX:GRA92)

Theseus Pharmaceuticals Statistics

Total Valuation

LUX:GRA92 has a market cap or net worth of EUR 18.59 billion. The enterprise value is 40.83 billion.

Market Cap	18.59B
Enterprise Value	40.83B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	Aug 5, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.08%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	333.31M

Valuation Ratios

The trailing PE ratio is 46.32 and the forward PE ratio is 201.52.

PE Ratio	46.32
Forward PE	201.52
PS Ratio	1.16
PB Ratio	1.09
P/TBV Ratio	2.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.47, with an EV/FCF ratio of -10.98.

EV / Earnings	101.75
EV / Sales	2.77
EV / EBITDA	14.47
EV / EBIT	18.58
EV / FCF	-10.98

Financial Position

The company has a current ratio of 0.87, with a Debt / Equity ratio of 1.19.

Current Ratio	0.87
Quick Ratio	0.33
Debt / Equity	1.19
Debt / EBITDA	6.67
Debt / FCF	-5.46
Interest Coverage	1.76

Financial Efficiency

Return on equity (ROE) is 5.23% and return on invested capital (ROIC) is 4.38%.

Return on Equity (ROE)	5.23%
Return on Assets (ROA)	2.99%
Return on Invested Capital (ROIC)	4.38%
Return on Capital Employed (ROCE)	5.56%
Revenue Per Employee	588,315
Profits Per Employee	14,683
Employee Count	27,327
Asset Turnover	0.33
Inventory Turnover	4.29

Taxes

In the past 12 months, LUX:GRA92 has paid 332.28 million in taxes.

Income Tax	332.28M
Effective Tax Rate	28.35%

Stock Price Statistics

The stock price has decreased by -6.51% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-6.51%
50-Day Moving Average	31.58
200-Day Moving Average	30.48
Relative Strength Index (RSI)	43.34
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LUX:GRA92 had revenue of EUR 16.08 billion and earned 401.24 million in profits. Earnings per share was 0.60.

Revenue	16.08B
Gross Profit	9.31B
Operating Income	2.36B
Pretax Income	1.17B
Net Income	401.24M
EBITDA	2.99B
EBIT	2.36B
Earnings Per Share (EPS)	0.60

Balance Sheet

The company has 2.59 billion in cash and 20.31 billion in debt, giving a net cash position of -17.72 billion.

Cash & Cash Equivalents	2.59B
Total Debt	20.31B
Net Cash	-17.72B
Net Cash Per Share	n/a
Equity (Book Value)	17.09B
Book Value Per Share	15.56
Working Capital	-1.51B

Cash Flow

In the last 12 months, operating cash flow was -1.86 billion and capital expenditures -1.86 billion, giving a free cash flow of -3.72 billion.

Operating Cash Flow	-1.86B
Capital Expenditures	-1.86B
Free Cash Flow	-3.72B
FCF Per Share	n/a

Margins

Gross margin is 57.88%, with operating and profit margins of 14.70% and 2.50%.

Gross Margin	57.88%
Operating Margin	14.70%
Pretax Margin	7.29%
Profit Margin	2.50%
EBITDA Margin	18.62%
EBIT Margin	14.70%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 0.30%.

Dividend Per Share	0.09
Dividend Yield	0.30%
Dividend Growth (YoY)	471.25%
Years of Dividend Growth	1
Payout Ratio	42.75%
Buyback Yield	-1.08%
Shareholder Yield	-0.78%
Earnings Yield	2.16%
FCF Yield	-20.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 19, 2016. It was a forward split with a ratio of 5.

Last Split Date	Oct 19, 2016
Split Type	Forward
Split Ratio	5

Scores

LUX:GRA92 has an Altman Z-Score of 0.88 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.88
Piotroski F-Score	2